Press "Enter" to skip to content

Analysis of Influenza Diagnostics Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to 2024

Influenza

The “Influenza Diagnostics Market” research report 2019 delivers comprehensive information about the market ranging from the establishment to the predictable growth trend. Influenza Diagnostics market report provides brief analytical data of the market contenders globally using advanced methodological approaches, such as SWOT analysis, production chain, cost, sales margin, financial details, recent developments. Influenza Diagnostics market report also offers market competitors that includes detailed company profiles along with company product specifications.

Market Overview:

  • The global influenza diagnostics market was valued at USD 492.42 million in 2018, and is estimated to be valued at USD 731.97 million in 2024, witnessing a CAGR of 6.83%. Certain factors that are driving the market growth include increasing prevalence of influenza and related chronic diseases, growth in research funding for influenza diagnostics, and rising demand for early diagnosis and control of influenza.
  • Influenza is recognized as a crucial cause of morbidity and mortality in the human population, which is leading to the development and use of diagnostics that are intended for reducing consequent health and economic impacts. According to WHO, in 2018, influenza caused severe sickness or death mainly in patients at a high risk and illness range from mild to severe and even death. Also, this annual increase is projected to result in about 3-5 million cases of severe illness, and about 290,000-650,000 deaths, globally.
  • Various initiatives and research funding are bolstering the growth of the market. For instance, National Institute of Allergy and Infectious Disease (NIAID) has supported a broad portfolio of the influenza research, which includes studies that are informing the development of vaccines, diagnostics, and therapeutics against seasonal and pandemic influenza. Similarly, in 2018, a non-profit association between academic, government, and industry medical researchers, called Human Vaccine Project, launched the Universal Influenza Vaccine Initiative. Thus, growth in research funding by the government and companies for influenza diagnostics is driving the market.
  • However, it is critical to ensure that all the rapid antigen flu tests meet new FDA requirements for approval. Hence, the stringent FDA regulations act as significant restraints for the market.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999593

    In Influenza Diagnostics Market Report, Following Companies Are Covered:

  • Abbott
  • Becton, Dickinson and Company
  • Coris BioConcept
  • DiaSorin SpA
  • F. Hoffmann
  • La Roche Ltd
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Sekisui Diagnostics
  • Thermo Fisher Scientific Inc.

    Influenza Diagnostics Market 2019 report will help the industry aspirants in arranging their strategies. The measurements offered in this report will be an exact and helpful manual to shape the business development. Additionally, will Provide historical data along with a future forecast and detailed analysis and also expected opportunities.

    Scope of the Report:

  • Influenza, also known as flu, is a highly contagious infectious disease caused by a virus. This is an infection of the respiratory passages, which causes fever and severe aches. The influenza diagnostic market includes the tests that are conducted for the diagnosis of influenza cases. As per the scope of this report, only the test kits and reagents that are being used for the diagnosis of influenza have been taken into account for the calculation of the total market size.

    Reasons for Buying Influenza Diagnostics Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999593

    Key Market Trends:

    Rapid Influenza Diagnostic Test (RIDT) is Expected to hold its Highest Market Share in the Test Type Segment

    In the test type segment of the influenza diagnostics market, among all traditional diagnostic tests, the rapid influenza diagnostic test (RIDT) is believed to have the largest market size and is expected to witness a CAGR of 6.87% during the forecast period.

    Rapid influenza diagnostic tests (RIDTs) are immunoassays, which help to identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and qualitatively provide the results. It can diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms.

    The rising popularity of RIDT is due to the benefits of faster result and simple usage. Some of the RIDTs are also approved for office/bedside use as well. The RIDT segment is also expected to witness rapid growth, as a result of their common usage in point-of-care settings.

    However, one of the major drawback associated with RIDT is that it gives false negative results, due to its low to moderate sensitivities (50-70%). Healthcare policymakers began to recognize the impact of its low sensitivity in 2009, when the novel H1N1 influenza epidemic occurred.

    North America Dominates the Market and is Expected to do the Same in the Forecast Period

    North America currently dominates the market for influenza diagnostics and is expected to continue its stronghold for a few more years.

    As per data published by the Centers for Disease Control and Prevention (CDC), RIDTs are commonly available across the region. The reason behind the wide availability of the test is the reduced time span needed to generate results. RIDT can yield results in 15 minutes. With increasing influenza-associated hospitalization and pediatric deaths and the interest of government organizations to better manage the disease, the North American influenza diagnostics market is expected to grow in the future.

    The Research Document Will Answer Following Questions Such as:

    • What are the cutting-edge technologies responsible for driving the growth of the market?
    • What are the main applications of the market? What are the growth prospects to the market applications into the market?
    • At what stage of development are the key market products?
    • What are the shortcomings that has to face to become commercially viable? Is their growth and commercialization dependent on cost declines or technological/application breakthroughs?
    • What is the outlook for the industry?
    • What difference does performance characteristics of Influenza Diagnostics create from those of established entities?

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/13999593

    Detailed TOC of Influenza Diagnostics Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Prevalence of Influenza and Related Chronic Diseases
    4.2.2 Growth in Research Funding for Influenza Diagnostics
    4.2.3 Rising Demand for Early Diagnosis and Control of Influenza
    4.3 Market Restraints
    4.3.1 Product Safety and High Cost of Development
    4.3.2 Stringent Government Regulations
    4.3.3 Variability in Sensitivity and Specificity among Influenza Diagnostic Tests
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Test Type
    5.1.1 Traditional Diagnostic Test
    5.1.1.1 Rapid Influenza Diagnostic Test (RIDT)
    5.1.1.2 Viral Culture
    5.1.1.3 Direct Fluorescent Antibody (DFA) Test
    5.1.1.4 Serological Assay
    5.1.2 Molecular Diagnostic Assay
    5.1.2.1 RT-PCR
    5.1.2.2 Nucleic Acid Sequence-based Amplification (NASBA) Test
    5.1.2.3 Loop-mediated Isothermal Amplification-based Assay (LAMP)
    5.1.2.4 Simple Amplification-based Assay (SAMBA)
    5.1.2.5 Other Molecular Diagnostic Assays
    5.2 End User
    5.2.1 Hospital
    5.2.2 Research Laboratory
    5.2.3 Other End Users
    5.3 Geography
    5.3.1 North America
    5.3.1.1 United States
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 United Kingdom
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Abbott
    6.1.2 Becton, Dickinson and Company
    6.1.3 Coris BioConcept
    6.1.4 DiaSorin SpA
    6.1.5 F. Hoffmann-La Roche Ltd
    6.1.6 Luminex Corporation
    6.1.7 Meridian Bioscience Inc.
    6.1.8 Quidel Corporation
    6.1.9 Sekisui Diagnostics
    6.1.10 Thermo Fisher Scientific Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Industrial Hydraulic Shock Absorber Market Share, Size 2019 Growing Rapidly with Modern Trends, Development, Revenue, Demand and Forecast to 2024 | Says Industry Research Biz

    Surgical Clippers Market 2019 Industry Recent Developments, Size, Trends, Global Growth, Recent Developments and Latest Technology, Forecast Research Report 2024

    Global Sparkling Bottled Water Market 2019 in-Depth Analysis by Market Size, Share, Key Players, and Regions, Business Expansion Plans Covered Forecast till 2025

    Dielectric Etchers Market 2019-2025 | Global Industry Extensive Competitive Landscape on Size, Volume, Trends, Share and Revenue with Leading Players Overview, Regional Forecast